Proprietary Stem Cell Technology Addressing Costly Heart and Liver Safety Challenges in Drug Development Drug Rescue Platform Designed to Recapture Prior Pharma R&D Investment in Once-Promising Drug Candidates Successfully Completed NIH-Funded Phase 1 Program for New Drug Candidate for Neuropathic Pain and Depression Experienced Management, Board, and Pharma Advisors Stem Cell Technology Aimed at Saving Billions of Healthcare
Share Structure of $VSTA - Share Structure Market Value1 $13,069,944 a/o Feb 27, 2013 Shares Outstanding 20,421,787 a/o Feb 21, 2013 Float 1,101,693 a/o Feb 21, 2013 Authorized Shares 200,000,000 a/o Feb 21, 2013